Global disruptions are exposing weaknesses in clinical supply chains. Learn practical strategies to build resilience, reduce waste, and protect trials from costly delays.
- The Fifth Model: Where It Works, Where It Doesn't, And The Economics Behind It
- Rethinking The Clinical Supply Chain: Practical Strategies For Slashing Trial Waste
- Optimizing Clinical Trial Logistics For On-Time Delivery
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
- The Biotech Road Map To Clinical Supply Resilience: 2026 And Beyond
- Lessons Clinical Supply Chains Can Learn From Freight Audit & Payment
- Beyond Push: A Pull-Based Model For Comparator Supply
- What Advanced Therapy Logistics Actually Need From Patient-Specific Supply Models
ON-DEMAND WEBINARS
Join Neta Bendelac from 4G Clinical and Limor Teomim from IMP CSS for an informative webinar as they explore how to mitigate the growing challenges faced as a result of the pandemic when it comes to DtP strategies and virtual trial design.
Understand state pharmacy regulations, prescription requirements, and operational considerations for shipping clinical supplies directly from pharmacies to patients' homes in decentralized trial models.
With so many moving parts in a clinical trial, why worry about the technology that is supposed to help manage it? In this webinar, explore five actionable and necessary strategies to leverage RTSM to simplify clinical trial operations.
Expert speakers discuss current operational obstacles and explore strategic solutions to optimize a supply chain strategy in the years ahead.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![DD 2 - 2mL_10mL_Vials_Tubs_Capped]( "Safeguarding Cell Therapy Cryopreservation: Primary Containers")
Safeguarding Cell Therapy Cryopreservation: Primary ContainersReview different aspects of container selection from the perspective of cryopreservation that are may be overlooked but critical for the quality of cell therapy drug products.
-
![trends-for-2025-GettyImages-2161094939]( "Outlook 2025: Key Trends & Insights")
Outlook 2025: Key Trends & InsightsDive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies.
-
![GettyImages-1327568875-technology-clinical trials-computer-medicine-research]( "Technology Solutions That Help Optimize Clinical Trial Distribution And Supply")
Technology Solutions That Help Optimize Clinical Trial Distribution And SupplyExplore how interactive response technology (IRT) can solve some common challenges of manually managed clinical trials and how to find the best IRT solution that meets clinical trial requirements.
-
![Quality Management GettyImages-1336716297]( "Quality Assured: Bringing Life-Changing Therapies To Patients")
Quality Assured: Bringing Life-Changing Therapies To PatientsBiopharmaceutical drug development remains a key trend, demanding specific expertise and capabilities when it comes to quality assurance. Explore four trends that matter in biologics for clinical trial supply.
-
![DD 3 - PFS Grouping 002]( "Lifecycle Planning For Containment And Delivery Of Biologics Drug Products")
Lifecycle Planning For Containment And Delivery Of Biologics Drug ProductsRead more about trends in the biologics market that could impact the lifecycle strategies for your drug product and steps you can take around drug packaging early in development.
-
![supply chain checklist pharmaceuticals-GettyImages-1616023386]( "Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes It")
Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes ItProtecting study integrity requires more than just luck. Learn how systemic gaps lead to unintentional unblinding and how a proactive, engine-based approach can safeguard your clinical data.
-
![GettyImages-1693748594 phone]( "RTSM: Randomization And Cohort Management, IP Inventory Management")
RTSM: Randomization And Cohort Management, IP Inventory ManagementSignant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
![Doctor Patient Engagement]( "Distributing Clinical Supply In The EU For Compassionate Use Programs")
Distributing Clinical Supply In The EU For Compassionate Use ProgramsExplore the logistical and distribution risk management factors that need to be considered when planning an EU Compassionate Use Program, especially when faced with COVID-19 closures and challenges.
-
![GettyImages-980809416 clinical supply]( "Consolidating Clinical Supply Chain Operations With GxP Inventory")
Consolidating Clinical Supply Chain Operations With GxP InventoryA Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
-
![supply chain management, pharma business logistics-GettyImages-960991960]( "What Is Interactive Response Technology (IRT)?")
What Is Interactive Response Technology (IRT)?Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
